GleamWall
中文EN

COGT Cogent Biosciences, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1622229 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-38.5%
TTM EPS YoY-10.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-99.6%
ROA-64.8%
ROIC (approx.)-89.9%
Asset turnover—

Leverage & solvency

Liabilities / assets38.0%
Debt / equity0.43x
Current ratio10.99x
Interest coverage-85.23x

Cash quality & payout

Operating cash flow / net income0.79x
Accruals ratio-13.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$269.78M$232.66M
SG&A expense$63.58M$43.28M
Operating income-$333.36M-$275.94M
Interest expense$3.06M—
Income tax$0—
Net income-$328.94M-$255.86M
EBITDA-$330.76M-$273.44M
EPS (basic)-2.16-1.94
EPS (diluted)-2.16-1.94
Weighted avg. shares (diluted)128.90M103.86M
Balance sheet
Cash & equivalents$312.01M$98.17M
Short-term investments$588.75M$188.91M
Current assets$910.36M$296.47M
PP&E, net$5.46M$6.47M
Total assets$937.61M$327.90M
Current liabilities$63.95M$55.71M
Long-term debt$222.90M$0
Total debt$222.90M$0
Total liabilities$301.24M$71.61M
Shareholders' equity$636.37M$256.29M
Net debt-$89.12M-$98.17M
Shares outstanding160.98M110.46M
Cash flow statement
Operating cash flow-$264.44M-$207.79M
Capital expenditure$1.55M$573,000
Free cash flow-$266.00M-$208.36M
Investing cash flow-$399.53M$38.28M
Financing cash flow$878.23M$214.45M
Depreciation & amortization$2.60M$2.50M
Stock-based compensation$46.08M$39.74M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.